Disc herniation (DH) is a common cause of spinal pain and radiculopathy. While most patients improve with conservative treatment, cases with persistent symptoms may require further intervention. In this context, interventional radiology (IR) offers image-guided, percutaneous techniques as a minimally invasive therapeutic option in the stepwise management of DH. This narrative review, conducted in accordance with SANRA principles, analyses the diagnostic and therapeutic role of IR in cervical, thoracic, and lumbar DH. A structured literature search was performed in PubMed/MEDLINE and Scopus to identify studies evaluating mechanical, thermal, chemical, and regenerative approaches. Reported outcomes included pain relief, functional recovery, complication rates, and need for reintervention. Evidence suggests that percutaneous intradiscal procedures may achieve meaningful short- and medium-term clinical improvement in carefully selected patients with contained herniations and clinicoradiological concordance. These techniques are associated with reduced invasiveness, shorter recovery times, and lower complication rates when performed by experienced practitioners. Imaging plays a central role in diagnosis, patient selection, procedural planning, as well as technical accuracy and safety. Nonetheless, current evidence remains heterogeneous and largely based on observational studies, with limited long-term comparative data. Further multicentre prospective trials and standardized outcome reporting are required to better define indications and lasting effectiveness.
Intra-articular platelet-rich plasma (PRP) injections represent a promising biological treatment for early-stage knee osteoarthritis (KOA). As cord blood-derived PRP (CB-PRP) contains higher levels of bioactive mediators, this prospective study aimed to compare the efficacy and safety of CB-PRP versus homologous donor PRP (HD-PRP) in patients with early KOA and to evaluate whether CB-PRP results in greater clinical improvement. Fifty-one patients aged 46–70 years with Kellgren–Lawrence grade 1–2 were randomized to receive either CB-PRP or HD-PRP. Each underwent three intra-articular injections at four-week intervals. Outcomes included pain-related overall health perception assessed by the EuroQol Visual Analogue Scale (EQ-VAS), function measured with the Knee Injury and Osteoarthritis Outcome Score (KOOS), and quadriceps muscle strength evaluated by dynamometry. Assessments were performed at baseline and at 1, 2, 3, 6, and 12 months. Both groups showed improvements in pain and function over 12 months, with no statistically significant between-group differences (p = 0.46). EQ-VAS increased from 59 ± 19 to 83 ± 9 in the CB-PRP group and from 59 ± 18 to 77 ± 18 in the HD-PRP group. KOOS improved from 50 ± 25 to 68 ± 23 and from 38 ± 28 to 59 ± 24, respectively. Quadriceps strength showed no intergroup differences. Adverse events were mild and self-limiting. Both treatments demonstrated comparable clinical benefits and favorable safety profiles.